But the drug doesn’t work, according to the Food and Drug Administration. Business Covis Pharma’s statement to The Times about Makena The FDA recommended that Covis Pharma’s premature birth drug, Makena, be taken off the market. “There is no way this drug should still be on the market.”A desktop display of the homepage of makena.com with information about the drug Makena. The company said it saw a billion-dollar “opportunity.”Billion-dollar opportunityThree years after the FDA approved Makena, yet another company acquired rights to the drug. Before it was acquired by Covis, AMAG had paid to be a member of the council since at least 2017, according to the league’s website.

Source: Los Angeles Times February 18, 2022 06:55 UTC